Home LiteratureArticle Details
PMID: 3512757 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.

The Journal of experimental medicine ·Vol. 163 ·No. 3 ·1986-03-01 ·Pages 632-43

Vilcek J, Palombella VJ, Henriksen-DeStefano D, Swenson C, Feinman R, Hirai M, Tsujimoto M

Abstract

Tumor necrosis factor (TNF) is a monocyte-derived protein cytotoxic or cytostatic for some tumor cell lines. Here we show that highly purified E. coli-derived recombinant human TNF stimulated the growth of human FS-4 diploid fibroblasts. Stimulation of cell growth was demonstrable at a TNF concentration of 10 pg/ml (3 X 10(-13) M). Maximal stimulation was attained at TNF concentrations of 10 ng/ml (3 X 10(-10) M) or higher. Growth-stimulatory activity of TNF was inhibited by an mAb neutralizing the cytotoxic activity of TNF. Growth stimulation was not inhibited by another mAb specific for TNF, lacking neutralizing activity for the cytotoxic activity of TNF. Growth stimulation by TNF was more marked and more sustained in the presence of greater than or equal to 10% FCS than in medium with less than or equal to 5% FCS. Addition of TNF to confluent FS-4 cultures also produced a marked stimulation of cell growth in the presence of fresh FCS, while a much less marked stimulation was seen in the absence of FCS. Stimulation of confluent cultures by TNF in serum-free medium was enhanced by insulin, suggesting that insulin or insulin-like growth factor(s) in the serum can act synergistically with TNF in producing growth stimulation. While the growth-stimulatory effects of TNF and insulin were synergistic, the actions of TNF and epidermal growth factor (EGF) were less than additive, suggesting that TNF and EGF may activate identical or similar pathways. We conclude that stimulation of cell growth is probably a physiological function of TNF, and that the cytotoxic and cytostatic actions of TNF may be the result of an anomalous growth signal transduction in neoplastic cells lacking the constraints of normal growth control mechanisms.

MeSH Terms
Cell Cycle/drug effects Cells, Cultured Contact Inhibition/drug effects Dose-Response Relationship, Drug Epidermal Growth Factor/pharmacology Fibroblasts/cytology Glycoproteins/pharmacology Growth Substances/pharmacology Humans Insulin/pharmacology Recombinant Proteins/pharmacology Tumor Necrosis Factor-alpha
Chemicals
Glycoproteins Growth Substances Insulin Recombinant Proteins Tumor Necrosis Factor-alpha Epidermal Growth Factor
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Vilcek J
Palombella V J
Henriksen-DeStefano D
Swenson C
Feinman R
Hirai M
Tsujimoto M
References (35)
35 references, click to expand
  1. Isolation of tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
    Cancer Res. 1985 Jun;45(6):2689-94 PMID: 3857121
  2. Type beta transforming growth factor: a bifunctional regulator of cellular growth.
    Proc Natl Acad Sci U S A. 1985 Jan;82(1):119-23 PMID: 3871521
  3. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.
    J Exp Med. 1985 May 1;161(5):984-95 PMID: 3872925
  4. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
    Science. 1985 Aug 30;229(4716):869-71 PMID: 3895437
  5. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin.
    Nature. 1985 Aug 8-14;316(6028):552-4 PMID: 2993897
  6. Reconstitution of functional receptor for human interleukin-2 in mouse cells.
    Nature. 1985 Dec 5-11;318(6045):467-70 PMID: 3934560
  7. Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.
    Proc Natl Acad Sci U S A. 1985 Nov;82(22):7626-30 PMID: 2999773
  8. Lymphocyte in vitro cytotoxicity: lymphotoxins of several mammalian species.
    Nature. 1968 Sep 7;219(5158):1076-7 PMID: 5673378
  9. Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism.
    J Exp Med. 1968 Dec 1;128(6):1267-79 PMID: 5693925
  10. An endotoxin-induced serum factor that causes necrosis of tumors.
    Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666-70 PMID: 1103152
  11. Cholera toxin stimulates division of 3T3 cells.
    J Cell Physiol. 1979 Mar;98(3):469-74 PMID: 220271
  12. Epidermal growth factor.
    Annu Rev Biochem. 1979;48:193-216 PMID: 382984
  13. Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity.
    J Biol Chem. 1980 May 25;255(10):4834-42 PMID: 6246084
  14. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors.
    Proc Natl Acad Sci U S A. 1980 Sep;77(9):5258-62 PMID: 6254071
  15. Human monocyte stimulation of fibroblast growth by a soluble mediator(s).
    J Reticuloendothel Soc. 1980 Dec;28(6):519-32 PMID: 6970264
  16. Human monocyte-derived growth factor(s) for mesenchymal cells: activation of secretion by endotoxin and concanavalin A.
    Cell. 1981 Sep;25(3):603-15 PMID: 7285115
  17. Cyclic AMP: a mitogenic signal for Swiss 3T3 cells.
    Proc Natl Acad Sci U S A. 1981 Jul;78(7):4392-6 PMID: 6270677
  18. The insulin-like growth factors (IGF) of human serum: chemical and biological characterization and aspects of their possible physiological role.
    Curr Top Cell Regul. 1981;19:257-309 PMID: 7037314
  19. Interleukin 1, a potential regulator of fibroblast proliferation.
    J Immunol. 1982 May;128(5):2177-82 PMID: 6460819
  20. Mitogenic activity elaborated by macrophage-like cell lines acts as competence factor(s) for BALB/c 3T3 cells.
    J Cell Physiol. 1982 Jan;110(1):93-100 PMID: 7068768
  21. Altered epidermal growth factor (EGF)-stimulated protein kinase activity in variant A431 cells with altered growth responses to EGF.
    Proc Natl Acad Sci U S A. 1982 Apr;79(8):2574-8 PMID: 6283535
  22. Characterization of a tyrosine-specific kinase activity in human fibroblast membranes stimulated by platelet-derived growth factor.
    J Biol Chem. 1982 Sep 10;257(17):10486-92 PMID: 6980882
  23. Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells.
    Exp Cell Res. 1982 Sep;141(1):107-15 PMID: 6749535
  24. In vitro synergism between interferons and human lymphotoxin: enhancement of lymphotoxin-induced target cell killing.
    J Immunol. 1983 Feb;130(2):518-20 PMID: 6600238
  25. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.
    Proc Natl Acad Sci U S A. 1983 Sep;80(17):5397-401 PMID: 6193516
  26. Epidermal growth factor (EGF) is required only during the traverse of early G1 in PDGF stimulated density-arrested BALB/c-3T3 cells.
    Exp Cell Res. 1983 Aug;147(1):202-8 PMID: 6604639
  27. Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin.
    J Exp Med. 1984 Mar 1;159(3):828-43 PMID: 6421983
  28. Selective reduction of c-myc mRNA in Daudi cells by human beta interferon.
    Proc Natl Acad Sci U S A. 1984 Mar;81(6):1747-50 PMID: 6584908
  29. The synergistic anti-proliferative effect of gamma-interferon and human lymphotoxin.
    J Immunol. 1984 Sep;133(3):1083-6 PMID: 6430995
  30. Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum.
    Clin Exp Immunol. 1984 Aug;57(2):293-300 PMID: 6467675
  31. Functional role for c-myc in mitogenic response to platelet-derived growth factor.
    Nature. 1984 Aug 23-29;310(5979):655-60 PMID: 6088986
  32. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene.
    Nature. 1984 Oct 4-10;311(5985):433-8 PMID: 6090941
  33. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):724-9 PMID: 6392892
  34. Spontaneous production of fibroblast-activating factor(s) by synovial inflammatory cells. A potential mechanism for enhanced tissue destruction.
    J Exp Med. 1985 Jan 1;161(1):210-22 PMID: 3968518
  35. Interleukin 2 inhibits in vitro growth of human T cell lines carrying retrovirus.
    J Exp Med. 1985 May 1;161(5):1243-8 PMID: 2985730
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1986-03-01
Pages
632-43
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2188056
Subset
IM
Grants
NIAID NIH HHS · AI-12948 · United States
NCI NIH HHS · CA-09161 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]